These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34907059)

  • 1. Women's conceptual knowledge about breast cancer screening and overdiagnosis in Norway: a cross-sectional study.
    Tsuruda KM; Veierød MB; Houssami N; Waade GG; Mangerud G; Hofvind S
    BMJ Open; 2021 Dec; 11(12):e052121. PubMed ID: 34907059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality-of-life effects of screening mammography in Norway.
    Zahl PH; Kalager M; Suhrke P; Nord E
    Int J Cancer; 2020 Apr; 146(8):2104-2112. PubMed ID: 31254388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of information about overdetection of breast cancer on women's decision-making about mammography screening: study protocol for a randomised controlled trial.
    Hersch J; Barratt A; Jansen J; Houssami N; Irwig L; Jacklyn G; Dhillon H; Thornton H; McGeechan K; Howard K; McCaffery K
    BMJ Open; 2014 May; 4(5):e004990. PubMed ID: 24833692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No overdiagnosis in the Norwegian Breast Cancer Screening Program estimated by combining record linkage and questionnaire information in the Norwegian Women and Cancer study.
    Lund E; Nakamura A; Thalabard JC
    Eur J Cancer; 2018 Jan; 89():102-112. PubMed ID: 29245077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mammography screening: A major issue in medicine.
    Autier P; Boniol M
    Eur J Cancer; 2018 Feb; 90():34-62. PubMed ID: 29272783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overdiagnosis of breast cancer in the Norwegian Breast Cancer Screening Program estimated by the Norwegian Women and Cancer cohort study.
    Lund E; Mode N; Waaseth M; Thalabard JC
    BMC Cancer; 2013 Dec; 13():614. PubMed ID: 24377727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modelling the overdiagnosis of breast cancer due to mammography screening in women aged 40 to 49 in the United Kingdom.
    Gunsoy NB; Garcia-Closas M; Moss SM
    Breast Cancer Res; 2012 Nov; 14(6):R152. PubMed ID: 23194032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trial.
    Hersch J; Barratt A; Jansen J; Irwig L; McGeechan K; Jacklyn G; Thornton H; Dhillon H; Houssami N; McCaffery K
    Lancet; 2015 Apr; 385(9978):1642-52. PubMed ID: 25701273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Obligate Overdiagnosis Due to Mammographic Screening: A Direct Estimate for U.S. Women.
    Hendrick RE
    Radiology; 2018 May; 287(2):391-397. PubMed ID: 29267146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's views on overdiagnosis in breast cancer screening: a qualitative study.
    Hersch J; Jansen J; Barratt A; Irwig L; Houssami N; Howard K; Dhillon H; McCaffery K
    BMJ; 2013 Jan; 346():f158. PubMed ID: 23344309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.
    Kalager M; Adami HO; Bretthauer M; Tamimi RM
    Ann Intern Med; 2012 Apr; 156(7):491-9. PubMed ID: 22473436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
    van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
    J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating Breast Cancer Overdiagnosis After Screening Mammography Among Older Women in the United States.
    Richman IB; Long JB; Soulos PR; Wang SY; Gross CP
    Ann Intern Med; 2023 Sep; 176(9):1172-1180. PubMed ID: 37549389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. US women's attitudes to false-positive mammography results and detection of ductal carcinoma in situ: cross-sectional survey.
    Schwartz LM; Woloshin S; Sox HC; Fischhoff B; Welch HG
    West J Med; 2000 Nov; 173(5):307-12. PubMed ID: 11069862
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
    Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
    JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Tailored Breast Screening Trial (TBST)].
    Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
    Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Do Women View Risk-Based Mammography Screening? A Qualitative Study.
    He X; Schifferdecker KE; Ozanne EM; Tosteson ANA; Woloshin S; Schwartz LM
    J Gen Intern Med; 2018 Nov; 33(11):1905-1912. PubMed ID: 30066118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspectives on mammography after receipt of secondary screening owing to a false positive.
    Thomson MD; Siminoff LA
    Womens Health Issues; 2015; 25(2):128-33. PubMed ID: 25648490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. US women's attitudes to false positive mammography results and detection of ductal carcinoma in situ: cross sectional survey.
    Schwartz LM; Woloshin S; Sox HC; Fischhoff B; Welch HG
    BMJ; 2000 Jun; 320(7250):1635-40. PubMed ID: 10856064
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.